Sensus Healthcare, Inc.

Sensus Healthcare, Inc.

SRTSยทNASDAQ

$3.09

-2.8%
HealthcareMedical - Devices

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

At a Glance

Live Snapshot
Market Cap$50.87M
EPS-0.4700
P/E Ratio-8.42
Earnings Date07/30/2026
3Y-38.0%
5Y+187.0%
10Y+86.0%
3Y-132.0%
5Y+13.0%
10Y+2128.0%
3Y-137.0%
5Y-222.0%
10Y-162.0%
Sensus Healthcare, Inc.

Sensus Healthcare, Inc. Profit Bridge

SRTS ยท NASDAQ
Revenue27.48M
Cost of Goods Sold (15.62M)
Gross Profit11.87M
Operating Expenses (22.17M)
Operating Income-10.31M
Interest Expense (0.00)
Other Income/Expense683.00K
Pretax Income-9.62M
Income Tax (-1.91M)
Net Income-7.72M
Net Income
-7.72M

Profitability Analysis

Gross Margin

43.2%

Strong gross margins indicate healthy pricing and efficient production or service delivery.

Operating Margin

-37.5%

Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.

Net Profit Margin

-28.1%

Net losses indicate the company is burning cash. Sustainability depends on path to profitability.

Profitability Insight

Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.

Sensus Healthcare, Inc. Income Statement

SRTS โ€ข NASDAQ

Sensus Healthcare, Inc. Income StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013
REVENUE
27.5M
41.8M
24.4M
44.5M
27M
9.6M
27.3M
26.4M
20.6M
14.8M
10.3M
5.8M
10.5M
GROSS PROFIT
(15.6M)
(17.4M)
(10.3M)
(14.9M)
(10.1M)
(4.3M)
(9.7M)
(9.5M)
(6.8M)
(5M)
(3.7M)
(2.1M)
(3.6M)
11.9M
24.4M
14.1M
29.6M
17M
5.2M
17.6M
16.9M
13.8M
9.8M
6.6M
3.8M
6.9M
OPERATING INCOME
(22.2M)
(16.3M)
(14.4M)
(14.8M)
(12.9M)
(13.5M)
(19.5M)
(18.9M)
(17.5M)
(10.2M)
(6.8M)
(7.4M)
(6.8M)
(14.4M)
(12.1M)
(10.8M)
(11.3M)
(9.4M)
(9.3M)
(13.1M)
(12.7M)
(12M)
(8.4M)
(5.3M)
(5.9M)
(5.4M)
(7.8M)
(4.2M)
(3.7M)
(3.5M)
(3.4M)
(4.2M)
(6.4M)
(6.3M)
(5.5M)
(1.8M)
(1.5M)
(1.6M)
(1.3M)
-10.3M
8.1M
-382K
14.8M
4.1M
-8.2M
-2M
-2M
-3.7M
-363.1K
-221.3K
-3.7M
126.8K
PRE-TAX INCOME
(0.0)
(0.0)
(0.0)
(2K)
(1K)
(14K)
(0.0)
(156.7K)
(68.9K)
(21.9K)
(17.8K)
(20K)
(20.5K)
683K
932K
992K
380K
1K
52K
268.3K
-17.4K
6.9K
16.7K
-16K
-19.2K
-19.2K
683K
932K
1M
13.2M
-1K
1.4M
268.3K
-17.4K
6.9K
16.7K
-16K
-19.2K
-19.2K
-9.6M
9M
652K
28M
4.1M
-6.8M
-1.7M
-2M
-3.7M
-346.4K
-237.3K
-3.7M
107.6K
NET INCOME
-1.9M
(2.4M)
(167K)
(3.7M)
(0.0)
(0.0)
-545.7K
(0.0)
(0.0)
(0.0)
(1.8K)
(820.0)
(0.0)
-7.7M
6.6M
485K
24.2M
4.1M
-6.8M
-1.7M
-2M
-3.7M
-346.4K
-237.3K
-3.7M
107.6K

SEC Filings

SRTS - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

June 02, 2026
May 29, 2026
2026
10-Q

10-Q 2026 Q1

Q1

May 13, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

May 07, 2026
May 07, 2026
2026
DEF 14A

DEF 14A 2026

N/A

April 29, 2026
May 29, 2026
2026
10-K

10-K 2025 FY

FY

March 04, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

February 12, 2026
February 12, 2026
2026
8-K

8-K 2026

N/A

January 20, 2026
January 13, 2026
2026
8-K

8-K 2026

N/A

January 12, 2026
January 05, 2026
2026
8-K

8-K 2025

N/A

November 13, 2025
November 10, 2025
2025
10-Q

10-Q 2025 Q3

Q3

November 12, 2025
September 30, 2025
2025
Showing 1 to 10 of 137 filings